Is This a Succession Risk?

Most succession planning discussions begin with senior leadership, and that is understandable. The departure of a CEO, executive or Board member has visible implications for the organisation and usually receives immediate attention. What is less visible is the risk created by people whose knowledge, relationships or technical judgement have gradually become essential to the business.

One of the most useful shifts an organisation can make is to stop thinking about succession only as the replacement of a person and begin thinking about it as the continuity of capability.

The distinction changes the conversation. Asking who could replace a particular leader encourages the organisation to think about candidates. Asking what would leave the organisation with that person reveals the knowledge, authority, relationships, judgement and organisational memory that may need to be preserved, transferred or rebuilt.

A CEO may have several credible internal or external successors, but still carry important investor or stakeholder relationships that are not shared elsewhere. A regulatory leader may have no formal executive title but hold years of knowledge about the organisation’s products, submissions and regulator interactions. A commercial leader may own relationships that appear to belong to the company but, in practice, depend heavily on personal trust. An operational specialist may understand the way a critical process actually works, including all the exceptions that were never captured in formal documentation.

These are different forms of succession risk, and they need different responses. Treating all of them as replacement questions can cause the organisation to overlook the real vulnerability.

A useful way to identify the risk is to consider four connected elements: ownership, concentration, transferability and time. These do not need to become a scoring exercise. They provide a way to examine what the organisation may be relying on without fully recognising it.

Ownership is about understanding what the person actually carries. Their formal responsibilities may be documented, but their practical contribution may extend much further. They may be the person colleagues approach when a difficult judgement is required, the person who holds important external relationships or the only person who understands why previous decisions were made.

Concentration considers how much of that capability sits with one individual. A function may appear well resourced, yet one person may still make the critical decisions, maintain the important relationships or hold knowledge that is not shared across the team. Headcount alone does not create succession depth.

Transferability examines whether the capability could realistically move to someone else. Some knowledge can be documented. Some responsibility can be redistributed. Some relationships can be broadened. Judgement developed through years of relevant experience is more difficult to transfer and may require a longer development or recruitment pathway.

Time considers how long the organisation would need to restore the capability if it disappeared. This is particularly important across healthcare and life sciences, where specialist expertise can be difficult to identify and where a new person may need substantial time to understand the organisation, its programmes, its stakeholders and its history.

Consider a healthcare business with an experienced operations leader who has been with the organisation through several periods of growth. The documented role may be replaceable. The less visible contribution may include knowledge of why services are structured in a particular way, established relationships across sites and the ability to recognise operational issues before they become significant. If that person left, recruiting someone with a similar title would address only part of the loss.

The practical response may involve developing another leader, sharing key relationships, clarifying decision rights and documenting important operating knowledge. It may also involve external talent mapping so the organisation understands how the market would respond if a future search became necessary. Succession planning, in this context, is not a search conducted early. It is a series of decisions that reduces dependency and preserves options.

A different example might involve a life sciences company with a highly experienced regulatory specialist. The organisation may initially conclude that the succession risk is low because there are other people in the function. A closer look may show that only one individual understands the full history of the programme, has led the critical regulator interactions and can connect scientific, clinical and regulatory decisions. The risk is therefore not the absence of other capable employees. It is the concentration of context and judgement in one person.

The response may not be to recruit an immediate replacement or create a deputy role. It may be to distribute ownership of regulator relationships, involve another person in key decisions, strengthen documentation and determine whether an internal successor could build the necessary depth over time. If the gap is too large or the timeframe too short, external market mapping may become appropriate before a vacancy exists.

This is where succession planning becomes more useful than maintaining a list of names. A named successor may appear reassuring, but the more important question is whether that person could carry the capability the organisation would lose. They may be ready for the title but not yet have the relationships, specialist knowledge or organisational authority required to assume the full mandate.

Readiness is therefore better considered against the future work than against the current incumbent. The organisation may not need someone who resembles the existing leader. It may need someone with different experience because the business itself is changing. A successor to a founder-led CEO, for example, may require a different mandate from the founder. A future functional leader may need to build a team and systems that were not necessary when the current leader first joined.

That means succession planning should not ask only, “Who could perform this role today?” It should also ask, “What will the organisation need from this role when the transition occurs?” The difference can change whether the best option is internal development, an external appointment or a redesign of the role itself.

The discussion becomes more decision-useful when the organisation distinguishes between immediate exposure and longer-term development. If a departure tomorrow would stop critical work, leave a significant decision without ownership or damage an essential relationship, the organisation has an immediate continuity risk. If the work could continue but no credible successor will be ready when the future role changes, the organisation has a development or market-readiness risk. Both matter, but they require different action and different timing.

An immediate risk may justify redistributing authority, creating greater knowledge depth or beginning a confidential external search. A longer-term risk may be addressed through development, broader exposure, revised responsibilities or talent mapping. The objective is not to remove all uncertainty. It is to understand which options are available while the organisation still has time to use them.

The conversation should also extend beyond the executive team. Board and CEO succession deserve careful attention, but specialist and functional roles can create material organisational exposure. Medical, clinical, regulatory, quality, market access, manufacturing, scientific, commercial and operational capability may all become difficult to replace when experience is highly concentrated.

A practical succession discussion should therefore leave the organisation able to state where its most consequential dependencies sit, what would actually be lost, how long recovery would take and which response is appropriate now. If the discussion produces only a list of possible replacements, it has probably not gone far enough.

The strongest succession planning does not predict exactly when someone will leave or prescribe a replacement years in advance. It gives the organisation a clearer view of where continuity depends too heavily on individuals, where future capability needs to be developed and where an informed understanding of the external market would create more choice.

See the risk before it becomes urgent

You may be considering CEO or Board succession, reviewing leadership depth or concerned about specialist knowledge concentrated within a small number of people. Hunton Executive can help you understand the capability at risk, assess the options available and determine whether the next step is development, talent mapping, interim support or search.

About Hunton Executive

Executive search, strategic headhunting, and specialist recruitment for healthcare and life sciences organisations. From Board appointments and executive leadership to the specialist capability around them. Permanent, interim and fractional.

We appoint the leader. We build the team.

Share

Related Articles